Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.
Similar Posts
Nature’s Fusions LLC – 707024 – 06/25/2025
CGMP/Finished Pharmaceuticals/AdulteratedHow to Participate in Emerging Technology Program (ETP)
CDER’s Office of Pharmaceutical Quality created the Emerging Technology Program to promote the adoption of innovative approaches to pharmaceutical product design and manufacturing.“Jeni’s Splendid Ice Cream Voluntarily Recalls Passion Fruit Dreamsicle Ice Cream Bars Due to Undeclared Wheat and Soy.”
Jeni’s Splendid Ice Creams is voluntarily recalling one batch of Passion Fruit Dreamsicle Ice Cream Bars because they may contain undeclared wheat and soy. People who have an allergy or severe sensitivity to soy and/or wheat run the risk of serious or life-threatening allergic reactions if they consCovalent Medical – 695839 – 07/09/2025
Unapproved New Drugs/MisbrandedRegulatory Submissions with Real-World Evidence: Successes, Challenges, and Lessons Learned – 09/23/2025
Opening Remarks by Sara Brenner, U.S. Food and Drug Administration
September 23, 2025MRI System Correction: Siemens Healthineers Issues Correction for 3 Tesla MRI Systems
Siemens Healthineers is correcting 3 Tesla MRI systems including MAGNETOM and BioGraph mMR due to the potential for ice blockage in the magnet venting system